235 related articles for article (PubMed ID: 23720150)
1. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
Golan T; Urban D; Berger R; Lawrence YR
Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
3. Population-based assessment of the surgical management of locally advanced colorectal cancer.
Govindarajan A; Coburn NG; Kiss A; Rabeneck L; Smith AJ; Law CH
J Natl Cancer Inst; 2006 Oct; 98(20):1474-81. PubMed ID: 17047196
[TBL] [Abstract][Full Text] [Related]
4. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
[TBL] [Abstract][Full Text] [Related]
5. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
Cummings LC; Payes JD; Cooper GS
Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
[TBL] [Abstract][Full Text] [Related]
6. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.
Coburn NG; Govindarajan A; Law CH; Guller U; Kiss A; Ringash J; Swallow CJ; Baxter NN
Ann Surg Oncol; 2008 Feb; 15(2):500-7. PubMed ID: 18026800
[TBL] [Abstract][Full Text] [Related]
8. Predicting survival for well-differentiated liposarcoma: the importance of tumor location.
Smith CA; Martinez SR; Tseng WH; Tamurian RM; Bold RJ; Borys D; Canter RJ
J Surg Res; 2012 Jun; 175(1):12-7. PubMed ID: 21920555
[TBL] [Abstract][Full Text] [Related]
9. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
11. Does young age influence the prognosis of colorectal cancer: a population-based analysis.
McKay A; Donaleshen J; Helewa RM; Park J; Wirtzfeld D; Hochman D; Singh H; Turner D
World J Surg Oncol; 2014 Dec; 12():370. PubMed ID: 25466394
[TBL] [Abstract][Full Text] [Related]
12. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
[TBL] [Abstract][Full Text] [Related]
13. Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis.
Renouf DJ; Lim HJ; Speers C; Villa D; Gill S; Blanke CD; O'Reilly SE; Kennecke H
Clin Colorectal Cancer; 2011 Jun; 10(2):97-101. PubMed ID: 21859560
[TBL] [Abstract][Full Text] [Related]
14. Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.
Brunner AM; Campigotto F; Sadrzadeh H; Drapkin BJ; Chen YB; Neuberg DS; Fathi AT
Cancer; 2013 Jul; 119(14):2620-9. PubMed ID: 23625575
[TBL] [Abstract][Full Text] [Related]
15. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
16. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic factors in colorectal carcinoma.
Deliu IC; Georgescu EF; Bezna MC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):808-16. PubMed ID: 25341305
[TBL] [Abstract][Full Text] [Related]
18. Outcome and prognostic features in adult pineoblastomas: analysis of cases from the SEER database.
Selvanathan SK; Hammouche S; Smethurst W; Salminen HJ; Jenkinson MD
Acta Neurochir (Wien); 2012 May; 154(5):863-9. PubMed ID: 22460262
[TBL] [Abstract][Full Text] [Related]
19. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
20. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
